|
|
 |
|
Lynestrenol
|
| Systematic (IUPAC) name |
(8R,9R,10R,13S,14S,17S)-17-ethynyl-13-methyl-
2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-
1H-cyclopenta[a]phenanthren-17-ol |
| Identifiers |
| CAS number |
52-76-6 |
| ATC code |
G03AC02 |
| PubChem |
5857 |
| Chemical data |
| Formula |
C20H28O |
| Mol. mass |
284.436 g/mol |
| Pharmacokinetic data |
| Bioavailability |
? |
| Metabolism |
? |
| Half life |
? |
| Excretion |
? |
| Therapeutic considerations |
| Pregnancy cat. |
?
|
| Legal status |
|
| Routes |
? |
Lynestrenol is a progestagen hormone.
|
Sex hormones and related agents (primarily G03, also L02, H01C) - human endogenous in CAPS |
|
Progestogens:
(receptor) |
|
Agonist
|
PROGESTERONE, Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, Tibolone
|
|
|
|
|
|
|
Antiprogestogen
|
|
|
|
Androgens:
(receptor) |
|
|
Estrogens:
(receptor) |
|
|
Gonadotropins:
(FSHR/LHCGR) |
|
|
GnRH:
(receptor) |
|
|
|
|
|
Could not update stat
|
|
